Physician profile
Amanda Arnp Collicott
NPI 1124486436
$615.90
in general payments reported to CMS, 2019-2025
9 companies · $173 in 2025
The $173 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $43.40 · 2022: $72.45 · 2023: $105 · 2024: $222 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $500.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $163.57 | 2022-2024 | Wegovy |
| Sanofi Pasteur INC. | $85.76 | 2023-2025 | |
| Insulet Corporation | $78.26 | 2023-2025 | Omnipod, Omnipod |
| Abbvie INC. | $78.18 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $52.59 | 2023-2025 | M-M-R II, Vaxneuvance, Vaxelis |
| Amgen INC. | $49.49 | 2025 | Krystexxa |
| Abbott Laboratories | $40.12 | 2024 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $35.60 | 2024-2025 | Bexsero, Pediarix, Rotarix |
| Neurocrine Biosciences, INC. | $32.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Collicott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.